OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levels
Kyung‐Soo Kim, Sangmo Hong, Kyungdo Han, et al.
Metabolism (2022) Vol. 137, pp. 155327-155327
Closed Access | Times Cited: 14

Showing 14 citing articles:

Exploring shared therapeutic targets in diabetic cardiomyopathy and diabetic foot ulcers through bioinformatics analysis
Hanlin Wu, Zheming Yang, Jing Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4

Fenofibrate and risk of end‐stage renal disease: A nationwide cohort study
Young Youl Hyun, Kyung‐Soo Kim, Sangmo Hong, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 10, pp. 4583-4590
Open Access | Times Cited: 4

Fenofibrate’s impact on cardiovascular risk in patients with diabetes: a nationwide propensity-score matched cohort study
Sangmo Hong, Kyung‐Soo Kim, Kyungdo Han, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3

Hypertriglyceridemia — current status of the problem. Part II: primary and secondary hypertriglyceridemias, treatment options
А. А. Семенкин, А. Н. Мешков, М. В. Ежов
Russian Journal of Cardiology (2025) Vol. 30, Iss. 2, pp. 6240-6240
Open Access

Clinical Characteristics of Patients With Statin Discontinuation in Korea: A Nationwide Population-Based Study
Kyung‐Soo Kim, Sangmo Hong, Kyungdo Han, et al.
Journal of Lipid and Atherosclerosis (2024) Vol. 13, Iss. 1, pp. 41-41
Open Access | Times Cited: 2

Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders
И. В. Сергиенко, М. В. Ежов
Russian Journal of Cardiology (2023) Vol. 28, Iss. 4S, pp. 5688-5688
Open Access | Times Cited: 4

Cardiometabolic benefits of fenofibrate in heart failure related to obesity and diabetes
Jiwon Park, Hangyul Song, Shinje Moon, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Atherogenic dyslipidaemia in type 2 diabetes mellitus: The PREDISAT study
Elisenda Climent, Jesús Millán, Juan F. Ascaso, et al.
Lipids (2023) Vol. 58, Iss. 4, pp. 197-206
Closed Access | Times Cited: 2

Biomarkers, Pandemics and Host Response Treatment
David S. Fedson
Journal of Nursing & Healthcare (2024) Vol. 9, Iss. 2, pp. 01-15
Open Access

Hypertriglyceridemia – a new and important present
О. В. Цыганкова, N. E. Apartseva, Ametov As
Endocrinology News Opinions Training (2023) Vol. 12, Iss. 4, pp. 99-111
Open Access | Times Cited: 1

Xây dựng và thẩm định phương pháp HPTLC để định lượng fenofibrat trong bán thành phẩm và viên nén
Phạm Lê Minh, Ngô Minh Thúy, Đào Thị Hương, et al.
Tạp chí Nghiên cứu Dược và Thông tin Thuốc (2023) Vol. 14, Iss. 6
Open Access

Page 1

Scroll to top